In support of this, a new pan-RAF/ MEK molecular glue that prevents phosphorylation and activation of MEK by RAF (NST-628), was recently developed and demonstrates activity across a diverse range of cancers driven by ERK signaling alterations (Ryan et al. 2024). Here, RAF1 is linked to cancer.